Unity Biotech (UBX) has disclosed a new risk, in the Regulation category. Unity Biotech faces significant risks due to potential noncompliance with regulatory standards, which could severely impact ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparatorIM1240's ...

The United States risks losing its competitive edge in artificial intelligence, quantum computing, and biotechnology unless ...

Semaglutide — better known by its brand names Ozempic (for diabetes) and Wegovy (for weight loss) — received FDA approval in 2017. Since then, U.S. prescriptions have surged from roughly 6.1 billion ...

Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has been concluded, with no prospects for further ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

Buy AbbVie (ABBV) stock? See more on its 2025 EPS growth outlook from Skyrizi/Rinvoq, valuation at 14.4x FY27, key risks, and ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On ...

Boston's life sciences cluster was built on the promise that if you earned a doctorate and came to Kendall Square, the jobs ...